Domino effect around next-generation Covid vaccine trial pushes Gritstone to cut 40% of staff

The FDA told the company to upgrade materials for a 10,000-person Covid vaccine trial, leading to the study's delayed and an expected payment related to the trial's launch not materializing.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news